The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

5-year USA distribution agreement

15 Feb 2021 07:00

RNS Number : 0224P
Surgical Innovations Group PLC
15 February 2021
 

Surgical Innovations Group plc

("Surgical Innovations", "SI" or the "Company")

 

5-year USA distribution agreement

 

Distribution agreement signed with Microline Surgical Inc for YelloPort+PlusTM and YelloPort EliteTM

 

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), announces a new USA distribution agreement with Microline Surgical Inc. ("Microline") for the Company's range of YelloPort+PlusTM and YelloPort EliteTM Access Devices. The 5-year agreement brings a significant opportunity to SI for growth in the US Trocar market.

 

Microline's sales & marketing structure is ideally placed to leverage their experience with Resposable surgical instruments to effectively drive US sales of YelloPort+PlusTM and YelloPort EliteTM Access Devices.

 

Based near Boston, MA, U.S.A. Microline designs, manufactures and distributes high quality instruments aimed at the MIS market. Its portfolio of products is complementary to those offered by SI with a focus on the resposable ethos of cost and sustainability. SI has a long established relationship with Microline, where it has an exclusive GB distribution agreement for Microline instruments that are complementary to the SI branded range.

 

Timothy Gehlmann, President & CEO of Microline, noted: "Microline is excited to add the YelloPort line of trocars from SI to our product portfolio. The SI trocar line complements our MIS instrument line by broadening our solution offering to customers."

 

Adam Power, Group Development Director at SI, added: "The United States accounts for almost half of the worldwide trocar market. Microline has a direct sales team with considerable experience in the selling of Resposable surgical devices. Microline and Surgical Innovations, through its UK subsidiary Elemental Healthcare, share a long history of synergy and growth and we are very excited to replicate this successful relationship in the United States."

 

For further information please contact:

Surgical Innovations Group plc

www sigroupplc com

David Marsh, CEO

Tel: 0113 230 7597

Charmaine Day, Co Sec & GFC

N+1 Singer (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell / Rachel Hayes/ Iqra Amin

Walbrook PR (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.

 

We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part re-usable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.

 

Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.

In addition, we design and develop medical devices for carefully selected OEM partners, and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.

 

We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs in the operating theatre environment.

 

The Group currently employs approximately 100 people across two sites in the UK. Product design, engineering and manufacturing are carried out at the SI site in Yorkshire. Commercial activities including marketing, UK distribution and international sales and marketing are based at Elemental Healthcare in Berkshire.

 

Further information

 

Further details of the Group's businesses and products are available on the following websites:

 

www sigroupplc com www surginno comwww elementalhealthcare co.uk

 

To receive regular updates by email, please contact si@walbrookpr.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRFLFSVFRISLIL
Date   Source Headline
11th Nov 20096:02 pmPRNGrant of Options
11th Nov 20093:38 pmPRNHolding(s) in Company
6th Nov 20093:41 pmPRNDirector/PDMR Shareholding
4th Nov 20095:26 pmPRNHolding(s) in Company
30th Oct 20093:03 pmPRNHolding(s) in Company
19th Oct 20092:23 pmPRNHolding(s) in Company
9th Oct 200912:34 pmRNSHolding(s) in Company
29th Sep 20097:00 amRNSInterim Results
24th Aug 200911:00 amRNSNotice of Results
20th May 20092:59 pmRNSResult of AGM
20th May 20097:00 amRNSAGM Statement
31st Mar 20097:00 amRNSFinal Results
30th Jan 20094:15 pmRNSHolding(s) in Company
28th Jan 20097:00 amPRNGrants of Options
26th Jan 20095:26 pmPRNCorrection : Director/PDMR Shareholding
22nd Jan 20097:00 amRNSNotice of Results
16th Jan 200911:49 amPRNDirector/PDMR Shareholding
12th Jan 20092:35 pmPRNHolding(s) in Company
29th Sep 20087:00 amRNSInterim Results
16th Sep 20087:00 amRNSNotice of Results
11th Jul 20087:00 amRNSDirectorate Change
25th Jun 20082:15 pmRNSResult of AGM
25th Jun 200812:00 pmRNSAGM Statement
23rd Jun 20087:00 amPRNDirector/PDMR Shareholding
13th Jun 20081:18 pmRNSNotice of AGM
8th May 20081:00 pmRNSChange of Company Address
29th Apr 20087:01 amRNSFinal Results
7th Apr 20087:00 amRNSNotice of Results
9th Nov 20077:01 amRNSGrant of Options
2nd Oct 20077:01 amRNSDirectorate Appointment
27th Sep 20077:02 amRNSInterim Results
14th Sep 20077:00 amRNSNotice of Results
20th Aug 20077:02 amRNSAIM Rule 26 Information
30th Jul 20077:01 amRNSUS Distribution Agreement
29th Jun 200712:13 pmPRNHolding(s) in Company
29th Jun 200711:44 amPRNTotal Voting Rights
25th Jun 20072:15 pmRNSResult of AGM
25th Jun 200712:00 pmRNSAGM Statement
22nd Jun 200711:34 amPRNHolding(s) in Company
22nd Jun 200711:19 amPRNHolding(s) in Company
11th Jun 200711:24 amPRNResult of EGM
21st May 200712:05 pmPRNHolding(s) in Company
17th May 20077:00 amPRNPlacing
30th Apr 20077:02 amRNSFinal Results
12th Mar 20073:41 pmPRNHolding(s) in Company
5th Mar 20077:01 amRNSNotice of Results
8th Jan 20077:01 amRNSTrading Update
29th Dec 20069:51 amPRNTotal Voting Rights
18th Dec 20067:01 amRNSUS hospital group Agreement
7th Sep 20067:02 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.